Revolutionizing TEE Imaging with Visura Technologies’ TEECAD Mini

Visura Technologies, a medical device company based in Minneapolis, is excited to announce the launch of its latest product, the TEECAD mini. This cutting-edge technology represents a significant milestone for the company, following an 85% increase in evaluations at prominent medical centers and the expansion of its clinical and commercialization teams.

The TEECAD mini-program is specifically tailored to address the needs of adult patients whose anatomical requirements are not met by standard TEE probe sizes. Building on the success of its FDA-cleared TEECAD System, Visura aims to enhance this cutting-edge technology to work with smaller probes.

At the upcoming American Society of Echocardiography (ASE) 2024 conference, Visura plans to gather feedback from key opinion leaders and showcase the benefits of the TEECAD System at its Innovation Station. Dr. David Marmor, founder and chief medical officer of Visura, highlighted the lack of notable advancements in TEE probe technology since the 1970s and emphasized the groundbreaking progress offered by TEECAD. Clinical data presented by Dr. Sunil Mankad of Mayo Clinic at last year’s ASE meeting demonstrated the safety and effectiveness of TEECAD in esophageal imaging, resulting in reduced probe placement time and increased success in first-pass intubation without any adverse events.

Visura remains committed to innovation, continuously expanding its product portfolio to address market demands and enhance patient care. The launch of the TEECAD mini represents another step towards providing state-of-the-art solutions for healthcare providers. To access more articles about medical technology developments, consider subscribing to our content today!